medicare glp-1 CMS Issues Coverage Guidance on Anti-Obesity Drugs What the Medicare GLP-1 Bridge

Theyre now pushing for an Office of Inspector General review before the website goes live

Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ

Oral semaglutide represents a paradigm shift in GLP-1 therapy accessibility, with extensive real-world evidence from 19 studies confirming comparable effectiveness and tolerability to injectable formulations in routine clinical scenarios [65]

The safety profile of retatrutide was consistent with that of other incretin-based therapies

Ultra-Processed Foods Processed foods and high-sugar items are both enemies of our health

A 2022 systematic review and meta-analysis of fibers impact on constipation concluded that dietary fiber sources can have a significant effect on constipation, especially at higher-than-average doses (adding 10 grams or more per day to your standard intake)